TB-500 alone is a systemic-acting peptide most clinically useful for broader cell migration and tissue remodeling demands
It is not licensed by the MHRA or EMA in the UK and is unavailable through NHS prescribing pathways as of 2025
Ask which medication class is most appropriate for your specific health situation, what weight loss and metabolic improvements you might realistically expect, what side effects are most likely and how they can be managed, how long you should expect to take the medication, what happens if you stop treatment, and what lifestyle changes should accompany medication therapy
If you are seeking high-dose glutathione therapy, you will need to meet with one of our practitioners to discuss your unique health needs
Quality assessment All included articles were evaluated using the Cochrane Collaborations tool [11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49], as outlined in Supplementary Table 3